Skip to main content
Premium Trial:

Request an Annual Quote

PositiveID, GenArraytion Partner to Test Pathogen Detection Dx Assays

NEW YORK (GenomeWeb) – PositiveID today announced that they have signed an agreement to partner with Rockville, Maryland-based GenArraytion.

Under the terms of the agreement, PositiveID will evaluate GenArraytion's assays on its Firefly Dx PCR prototype pathogen detection system.

GenArraytion's MultiFlex Bioassays for pathogens can feature up to 20 DNA or RNA targets per panel, and are designed for use with real-time or bead-based platforms. The configurable, mix-and-match assays have been developed for clinical pathogens, veterinary pathogens, food- and water-borne pathogens, and biological threats.

Financial and other details of the agreement were not disclosed.

In May 2014, Del Ray Beach, Florida-based PositiveID signed a deal to develop military applications for the Firefly Dx system.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.